Abstract
Lung cancer is the second most common malignancy and the leading cause of cancer-related death worldwide. It is critical to understand lung cancer tumor biology to better predict cancer behavior across various populations. This study aimed to evaluate differences in genomic alterations in patients with advanced non-small cell lung cancer (NSCLC) and is an update to a prior abstract.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
